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Targeting latent infection within resting CD4+ T cells
might lead to better control, and perhaps eradication of
HIV infection. Histone deacetylase 1 (HDAC1) plays a
central role maintaining HIV latency. HDAC inhibition
augments HIV promoter and viral expression without glo-
bal T cell activation or increased de novo HIV infection.
We tested the ability of the HDAC inhibitor valproic acid
(VPA) to deplete replication-competent HIV in vivo
within the resting CD4+ T cell pool in stably aviremic,
patients on standard combination antiretroviral therapy
(ART).
We intensified therapy by the addition of enfuvirtide (T-
20) agent prior to VPA treatment. Four volunteers with
plasma HIV RNA < 50 copies/ml for mean of >46 months
added T-20 for 4–6 weeks, and then VPA to their therapy
for 3 additional months. The frequency of replication-
competent HIV in resting CD4+ T cells was enumerated by
limiting-dilution culture of maximally activated resting
CD4+ T cells.
Repeated assays within patients did not demonstrate a
decline of resting cell infection on ART. A significant
decline (mean reduction 75%; range 68% to >84%)
occurred in three of four patients after treatment with T-20
and VPA.
Initial data in ongoing studies of ART and VPA without
intensification demonstrate depletion of latent infection
in some patients. Laboratory studies of other HDAC
inhibitors and of other mechanisms that contribute to
persistent, quiescent proviral infection suggest that clini-
cal strategies may eventually be developed that can induce
expression and clearance of HIV, and avoid the need for
lifelong ART in some patients.
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